Aurora Cannabis (NYSE: ACB), once a favorite among pot investors because of its bold expansion strategy, lost steam in 2019. Aurora's shares declined 56% last year, compared to a 36% decline of the industry benchmark, the Horizons Marijuana Life Sciences Index ETF. Marijuana sales have been rising in 2020, particularly because of the coronavirus pandemic, which has amplified consumer demand. Read More...
Aurora Cannabis (NYSE: ACB), once a favorite among pot investors because of its bold expansion strategy, lost steam in 2019. Aurora’s shares declined 56% last year, compared to a 36% decline of the industry benchmark, the Horizons Marijuana Life Sciences Index ETF. Marijuana sales have been rising in 2020, particularly because of the coronavirus pandemic, which has amplified consumer demand.
Add Comment